Articles

Hollywood, FL—With the Affordable Care Act about to be fully enacted, and growing concerns about managing oncology costs, health plans will put simple processes in place ahead of new drug approvals to more actively manage these medications, said James T. Kenney, Jr, RPh, MBA, Pharmacy Operations Manager, Harvard Pilgrim Health Care, Wellesley, MA, at the Third Annual Conference of the Association for Value-Based Cancer Care.

Hollywood, FL—In response to mandates for more efficient and lower-cost cancer drug utilization, CVS Caremark is developing innovative strategies, said Kirby J. Eng, RPh, Director of On­co­logy Medical Pharmacy Manage­ment, CVS Caremark, at the Third Annual Conference of the Association for Value-Based Cancer Care.

Orlando, FL—In screening colonoscopies, high adenoma detection rates (ADRs) by physicians are associated with fewer missed cancers and with better survival from colorectal cancer (CRC), according to 2 studies presented at Digestive Disease Week 2013.

Chicago, IL—For-profit hospitals are more likely than their nonprofit counterparts to treat elderly patients with breast cancer with an expensive form of radiotherapy—despite lacking evidence of its benefit, researchers from the Yale Cancer Outcomes, Public Policy and Effectiveness Research Center reported at the 2013 American Society of Clinical Oncology annual meeting.

Chicago, IL—The rapid advances in cancer treatment, especially in personalized medicine, are occurring at an enormous financial cost to the healthcare system.

Chicago, IL—“Building Bridges to Conquer Cancer” was the theme of the 2013 American Society of Clinical Oncology (ASCO) annual meeting, as well as of the address of ASCO’s outgoing President Sandra M. Swain, MD.

The past several years have seen significant consolidation in the healthcare industry. The cost of healthcare in the United States is currently estimated to be 18% of the gross domestic product (GDP), and the costs are projected to increase disproportionately to the GDP during the next decade.

A new study led by researchers at the National Institutes of Health shows that a set of proteins in the body produces a large number of mutations in human DNA, indicating that these naturally produced mutations are just as powerful as cancer-causing agents in producing tumors.

Many presentations at the 2013 annual meeting of the American Society of Clinical Oncology (ASCO) focused on new research involving immunotherapy, including drugs for melanoma and lung cancer that have shown great success in prolonging life in patients with advanced disease.

Quality measures and patient satisfaction are increasingly being tied to a proportion of physicians’ reimbursement, according to a new report from the Medical Group Management Association-American College of Medical Practice Executives (MGMA-ACMPE), “Physician Compensation and Production Survey: 2013 Report Based on 2012 Data.”